The size of the global blood group typing market will reach USD 4.2 billion by 2024 from USD 2.6 billion in 2019. This market to showcase a CAGR of 9.9% during the forecast period 2019 - 2024.
BLOOD BANKS ACROSS THE WORLD IS DRIVING THE GROWTH OF THE MARKET
Increasing prevalence to identify the blood group of an individual in the medical sector is a key driving factor for the blood group typing market to grow. The growing number of blood banks across the world is accelerating the demand of the market. Besides, increasing accidental cases and the need for blood in emergency cases are propelling the need for the market.
Rising incidences of chronic diseases and the growing number of surgical treatment procedures are greatly influencing the growth of the global blood group typing market. Increasing blood donation campaigns even in the rural areas, is gearing up the demand of this market. The emergence of latest technologies in the medical sector is to set up growth opportunities for the market.
However, negligence of the staff members in maintaining correct formats is quietly hindering the demand of the market. Cost for installation and maintenance of the devices are a little expensive, and this remained a challenging factor for the market developers.
Recent Developments in the Blood Group Tying Market:
Product Initiative - In 2017
The Philippines launched a free blood group typing scheme. In this initiative it is easy to identify possible blood donors through times of disease outbreak and the title of this campaign was "Type ng Bayan" sponsored by health government departments along with the collaboration of DU30 cabinet spouses.
Product Approval - In late 2016
The U.S. Food and Drug Administration (FDA) approved Immucor's Precise Type HEA test and its use in the identification of sickle cell characteristics in blood donors. Many regulatory agencies, such as the FDA are involved in the development and application of uniform access to reliable blood policies at the country level.
Acquisition - In Jan 2017
Grifols has completed the acquisition of Hologic in 2017. In this acquisition company mainly focussed on research, production, assay manufacturing, NAT (Nucleic Acid Testing) technology-based instruments for transfusion and transplantation screening.
Acquisition - In June 2014
Carlyle Group bought Ortho-Clinical Diagnostics, Inc. for about USD 4 billion in late 2014. Through this purchase, the business has invested in Research and Development throughout the world for medical diagnostic products and services.
Acquisition - In 2014
Immucor, Inc., a world leader in diagnostics for transfusion and transplantation, confirmed its acquisition of Mountain View, Sirona Genomics (Sirona), headquartered in CA, at the end of 2014. Under this, Immucor aimed to provide research funding to support the promotion of Sirona's HLA model sample preparation and bioinformatics service using leading NGS methods.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 – 2024 |
|
Forecast Units |
Millions (USD) |
|
Segments Analysed |
By Product, Test Type, Technique, End User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, APAC, Latin America and MEA |
|
Companies Profiled |
Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST and AXO Science |
This report on Global Blood Group Typing Market has been segmented and sub-segmented based on technique, product type, test type, end-user and region.
By Technique
Based on the Technique, consumables segment hold the largest market share value due to the growing increase of surgical processes and usage of laboratories.
By Product Type
Based on the Product Type, the PCR-based and Microarray Techniques segment is likely to hold the largest market share value of Blood Group Typing due to growing aged people population and also the number of people population increasing with different kinds of health issues.
By Test Type
Based on the Test Type, the Antibody screening segment is expected to have an important growth during the period which is attributed due to growing demand for quick diagnosis of the diseases that are suffering with, is producing maximum advantages for the growth during the rate.
By End-User
Based on the end-user type, hospitals segment is likely to have an intense growth during the period due to having more knowledge in people about the blood group.
NORTH AMERICA IS LEADING THE SHARES OF THE MARKET
Based on the region, North America is holding the most significant shares in the global blood group typing market with the rise in the capital income in most of the countries. Launch of various new techniques in the medical sector to enable easy identification of blood groups is bolstering the demand of this market.
With the increasing population and rise in applications in forensic sciences to identify the blood group from samples collected.The Middle East and Africa to have inclined growth rate in coming years.
Key companies dominating the Global Blood Group Typing Market Profiled in the Report are:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.2.1 Antisera Reagents
5.1.2.2 Red Blood Cell Reagents
5.1.2.3 Anti-Human Globulin Reagents
5.1.2.4 Blood Bank Saline
5.1.3 Instrument
5.1.4 Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Test Type
5.2.1 Introduction
5.2.2 ABO
5.2.3 Antigen
5.2.4 Antibody Screening
5.2.5 Cross Matching
5.2.6 HLA
5.2.7 Y-o-Y Growth Analysis, By Test Type
5.2.8 Market Attractiveness Analysis, By Test Type
5.2.9 Market Share Analysis, By Test Type
5.3 Technique
5.3.1 Introduction
5.3.2 Assay
5.3.3 PCR
5.3.4 Microarray
5.3.5 Massively Parallel Sequencing
5.3.6 Y-o-Y Growth Analysis, By Technique
5.3.7 Market Attractiveness Analysis, By Technique
5.3.8 Market Share Analysis, By Technique
5.4 End-User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Clinical Laboratories
5.4.4 Blood Banks
5.4.5 Other End Users
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Test Type
6.1.3.4 By Technique
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Test Type
6.1.4.4 By Technique
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Test Type
6.1.5.4 By Technique
6.1.5.5 By End User
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Bio-Rad Laboratories Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Grifols S.A.
8.3 Immucor Inc.
8.4 Ortho Clinical Diagnostics Inc.
8.5 Quotient Ltd.
8.6 Novacyt Group
8.7 BAG Healthcare GmbH
8.8 Rapid Labs
8.9 Day medical SA
8.10 DIAGAST
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
